Identification and quantitation of cellular proteins associated with HIV-1 particles are complicated by the presence of nonvirion-associated cellular proteins that copurify with virions. Many cellular proteins are associated with nonviral particles that bud from the surface of cells called microvesicles. Microvesicles band in sucrose gradients in a range of densities that includes the same density as retroviruses. To characterize these microvesicles, HIV-1-infected and uninfected human T-cell lines were propagated and virus and microvesicles were purified from clarified cell culture supernatants by sucrose density gradient centrifugation or centrifugation through 20% sucrose pads. Microvesicles were found to contain various proteins, including HLA DR and b2-M, and a substantial amount of RNA and DNA. The concentrations of HIV-1 p24 CA
INTRODUCTION
1987; Schols et al., 1992; Arthur et al., 1992; Meerloo et al., 1993; Orentas et al., 1993; Gluschankof et al., 1996) , Certain cellular proteins can associate with retroviidentification and analysis of cellular proteins located ruses, including the immunodeficiency viruses HIV-1 and internal to the virus are complicated by the presence of SIV, by incorporation into the viral membrane or interior. cellular membrane vesicles which copurify with the virus. Some of the cellular proteins that associate with the We recently reported a proteolytic procedure (Ott et al. , membrane of immunodeficiency viruses have been 1995b) that effectively removes greater than 95% of proshown to serve as protective immunogens in vaccination teins associated with these membrane vesicles. This experiments. Other cellular proteins, located at the inteprocedure has allowed us to demonstrate that the cyrior of the virus, appear to be necessary for HIV-1 infectoskeletal proteins, actin, ezrin, moesin, and cofilin are tion. Stott (1991) reported that 2 of 4 macaques immulocated in the interior of virions (Ott et al., 1996) . Although nized with human cells were protected from infection we previously used the term mock virus to refer to the when challenged with SIV propagated in the same humembrane vesicles present in purified viruses (Arthur man cells, indicating that an immune response to cellular et al., 1995) , the particles are strikingly similar to small proteins may afford protection from challenge. Immunizabudding membrane particles frequently called microvestion and challenge experiments with purified cellular proicles. It therefore appears to be more appropriate to use teins, previously shown to be associated with the memthe term microvesicles when referring to these membrane of immunodeficiency viruses , brane particles. In this report we identify and partially revealed that monkeys with an immune response to HLA characterize microvesicles from human T-cell lines and DR or HLA class I were protected from challenge with PBL that constitute a significant source of cellular pro-SIV propagated in human cells (Arthur et al., 1995;  Chan teins found in purified preparations of immunodeficiency et al., 1995) . Cyclophilin A has been shown to specifically viruses, including HIV-1. associate with p24
CA in HIV-1 virions and this cellular protein appears to be necessary for HIV-1 infectivity MATERIALS AND METHODS (Franke et al., 1994; Thali et al., 1994; Braaten et al., 1996) . While virion-associated cellular proteins located
Cell culture on the virus surface can be identified by immunological HIV-1(B)-infected H9 cells [HIV-1(B)/H9] (Popovic et al., techniques (Gelderbloom et al., 1987; Kannagi et al., 1984) , HIV-1(MN) infected H9 cells [HIV-1(MN)/H9] (Reitz et al., 1992) , and H9 cells (Popovic et al., 1984; Mann et al., 1989) , were obtained from Dr. Robert Gallo (NCI).
Peter Nara (NCI-FCRDC), MOLT-3 cells . The HIV-1 preparation was treated with a final concentration of 0.5% Triton X-100 to solubilize al., 1972) were obtained from Advanced Biotechnologies Laboratories (Columbia, MD), and DAUDI-CD4 cells were p24 CA and other proteins. After centrifugation at 100,000 g to pellet nonsolubilized material, the supernatant was obtained from Dr. Paul Clapham (Chester Beatty Laboratories, England). HIV-1(MN)/H9 Clone 4 was prepared by loaded onto the immunoaffinity column. The column was washed to baseline (A 280 ) using PBST and p24 CA eluted Dr. Steve Nigida (AVP) and is a single-cell clone of HIV-1(MN)/H9 prepared by limiting dilution (Ott et al., 1995a) .
with 0.1 M citrate, pH 2.5. The eluate was titrated to pH 7.0 with 0.1 M K 3 PO 4 . HLA DR4 was similarly purified HIV-1(MN) Clone 4/CEM, HIV-1(MN) Clone 4/MOLT-3, and HIV-1(MN) Clone 4/DAUDI-CD4 were prepared by from H9 cell lysates by immunoaffinity chromatography using a mouse monoclonal antibody prepared against infecting the respective uninfected parental cell lines with cell free HIV-1(MN) Clone 4 virus. For large-scale HLA DR1, LB3.1 (provided by Dr. J. Strominger, Harvard University), that cross reacts with HLA DR4. Purified huproduction, all cell lines were grown in suspension culture using 850-cm 2 roller bottles (Corning). Cultures were man b2-M was purchased from Valley Biomedical Products and Services, Inc. HIV-1(MN) recombinant gp120 SU maintained in RPMI 1640 supplemented with 5% heatinactivated fetal bovine serum (Biofluids Inc.), 2 mM Lwas obtained from Genentech (San Francisco, CA). glutamine, 100 U/ml penicillin, and 100 mg/ml streptomyRadioimmunoassays (RIA) cin. Each roller bottle contained 400 ml of medium and was incubated at 37Њ while rotating at 0.75 rpm on roller Radioimmunoassays were performed essentially as racks. Cultures were harvested at 3-to 4-day intervals previously described . by decanting 200 ml from each roller bottle and refeeding with 200 ml of fresh medium.
Electron microscopy
Approximately 5 1 10 6 cells were removed from a 3-Purification of HIV and microvesicles day culture and centrifuged at 1000 rpm for 10 min at 4Њ. Virus and microvesicles were purified as described
The cell pellet was fixed with 1.25% gluraldehyde. Thin . Briefly, virus and microvesicles were sections were prepared as previously described (Gehle purified from clarified cell culture supernatants by two and Smith, 1970), treated with lead citrate, and analyzed successive ultracentrifugations in sucrose density gradiby transmission electron microscopy. ents (double banded). Virus-or microvesicle-containing fractions were identified by UV absorption at 280 and 254 DNA and RNA quantitation nm. Peak UV absorbing fractions were pooled, diluted to Pellets of purified H9-microvesicles, containing 20 mg below 20% sucrose with TNE buffer [0.01 M Tris-HCl of protein (measured by the Lowry method), were each (pH 7.2), 0.1 M NaCl, and 1 mM EDTA in deionized water], disrupted with 2 ml of guanidine isothiocyanate solution ultracentrifuged to a pellet, and resuspended in TNE.
as described in Davis et al. (1986) . To isolate RNA, one Samples were stored at 070Њ. dissolved pellet was layered over 2.0 ml of a 96% (wt/ vol) CsCl solution that was prepared as described in Total protein determinations Davis et al. (1986) . Another dissolved pellet was layered Protein concentrations were determined using the over a 67% (wt/vol) CsCl cushion for the purpose of isolatFolin phenol reagent (Lowry et al., 1951) . Prior to ing DNA and RNA. The 67% cushion had the same soassaying, samples were solubilized by the addition of dium acetate concentration and pH as the 96% (wt/vol) Sarkosyl detergent to a final concentration of 0.2%. BoCsCl cushion. The tubes were topped off with the guanivine serum albumin (Sigma) was used as the standard. dine isothiocyanate solution. Samples were centrifuged at 42,000 RPM for 18.5 hr at 20Њ in an SW60 Rotor (Beck-SDS-polyacrylamide gel electrophoresis (SDS-PAGE) man Instruments, Inc., Fullerton, CA). The tubes were drained, the walls wiped, and the RNA or RNA/DNA pelSamples were analyzed by discontinuous, sodium dolets were resuspended in 250 ml of diethylpyrocarbonatedecyl sulfate-polyacrylamide gel electrophoresis (Laemtreated water. mli, 1970) .
Single-stranded RNA concentrations were determined using an OD 260 nm of 1.0 being equal to 40 mg/ml. DoublePurified proteins stranded DNA concentrations were determined using an OD 260 nm of 1.0 being equal to 50 mg/ml (Ausubel et al., CA was purified to homogeneity from sucrose density gradient purified HIV-1(MN)/H9 by immunoaffinity 1995). DNA levels were determined by subtracting the RNA absorbance of the RNA containing sample, from the chromatography. A mouse monoclonal antibody against HIV-1 24
CA was coupled to cyanogen bromide activatedabsorbance of the RNA/DNA sample. The resulting OD 260 difference was then used to calculate DNA levels in the Sepharose 4B (Sigma) following the manufacturer's recommendations and equilibrated against phosphate-bufpellet. The purity of the isolated nucleic acid was assessed by measuring the A 260 /A 280 ratio. At either the 96% fered saline (Dulbecco's formulation) containing 0.1% Tri-or 67% (wt/vol) CsCl concentrations, proteins remain at the uninfected parent lines listed in Table 1 . After clarification to remove the cells, the supernatant was centrior above the guanidine isothionate/CsCl interface. According to the protocol described for the isolation of RNA fuged at 100,000 g for 45 min and the pellet was resuspended in 30 ml of sterile buffer. This material was centri- (Davis et al., 1986) , with a 96% (wt/vol) CsCl cushion, RNA pellets through the cushion, and DNA bands within the fuged through a 20 ml-20% sucrose pad at 100,000 g for 1 hr. Visible pellets were found in all preparations, CsCl cushion. This laboratory has determined that both DNA and RNA pellet through a 67% (wt/vol) CsCl cushion.
including the material from uninfected cells. Finally, the pellets were resuspended in TNE buffer at 5001 relative Additionally, quantitative recoveries of DNA can be obtained for levels of DNA or RNA greater than 1 mg. When to the starting cell culture supernatant. Detergent disrupted samples of each preparation were analyzed by 1 mg of HindIII digested l DNA is centrifuged through a 67% (wt/vol) CsCl cushion, 100% recoveries of DNA are Lowry assay, HIV-1 p24 CA RIA, HLA DR RIA, and b2-M RIA. All cell lines, including the uninfected parental lines, obtained. This was determined by comparing the intensities of the ethidium stained l DNA fragments after fracproduced particulate-proteinaceous material dense enough to penetrate 20% sucrose during centrifugation. tionation on a 1% agarose gel, before and after passing through the 67% (wt/vol) CsCl cushion (data not shown).
As seen in Table 1 , the p24 CA concentration of the HIV-1(MN)/H9 Clone 4 preparation was substantially higher than those of the two prototypical HIV-1 producing cell Identification of RNA species lines, HIV-1(B)/H9 and HIV-1(MN)/H9, indicating greater RNA samples were fractionated by formaldehyde agavirus yield. The HIV-1(MN) Clone 4-infected CEM-SS, rose gel electrophoresis, transferred to nitrocellulose, DAUDI, and MOLT-3 cells also provided good virus and probed as described previously (Gorelick et al., yields. HLA DR antigens were detected in virus and mi-1990). RNA samples were loaded in the presence of 2.5 crovesicle preparations from all cell lines that express mg of ethidium bromide. The filter was hybridized in the HLA DR (H9 and DAUDI). Also, b2-M was found in the following order with an 8088 BP Aval HIV-1 fragment virus and microvesicles produced from all the cell lines (from pNL4-3) that was 32 P-nick translated and a 32 P-nick that express this protein (H9, CEM-SS, and MOLT-3). translated human glyceraldehyde 3-phosphate dehydroNotably, the amount of HLA DR exceeded the amount of genase (G3PDH) cDNA probe from Clontech Laborap24 CA in some virus preparations. As an index of relative tories, Inc. (Palo Alto, CA). The filter was stripped bepurity, the ratio of viral p24 CA concentration to the sum tween hybridizations with boiling water.
of the HLA DR and b2-M concentrations was calculated for each preparation. The HIV-1(B)/H9 Clone 4 preparaPreparation of microvesicles from human PBL tion was significantly more pure in this sense than the two prototypical HIV-1 producing cell lines, HIV-1(B)/H9 The peripheral blood lymphocytes (PBL) from a lymphand HIV-1(MN)/H9. However, much better ratios were apheresis pack were recovered by centrifugation in 1.077
found for the HIV-1(MN) Clone 4/CEM-SS and HIV-1(MN) g/liter Ficoll-Hypaque at 900 g for 20 min at 20Њ. The Clone 4/Daudi. resulting cells (7.5 1 10 8 cells total) were washed twice Sixteen double-banded preparations of H9 microveswith PBS and used to seed 850-cm 2 roller bottles at a icles were prepared by double banding in sucrose gradidensity of 1,000,000 viable cells/ml using complete RPMI ents as described under Materials and Methods. The pri-1640 containing 2 mg/ml PHA. The cultures were incumary banding was in a 20 to 60% (1.08 to 1.29 g/ml) subated for 2 days at 37Њ at 0.75 rpm. The PHA was recrose density gradient. UV absorbing material was moved by washing with PBS and PBLs were scaled up detected in all portions of these gradients and the peak in complete RPMI 1640 containing 50 units/ml of IL-2.
absorbing material was found at 1.13 g/ml. The average Cultures were harvested twice per week until a total of protein yield was 1.36 { 0.37 mg per liter of cell culture 10 liters of cell culture was produced. Cells were resupernatant ({1 standard deviation). For comparison, moved by centrifugation and microvesicles were recovdouble-banded HIV-1(MN)/H9 and HIV-1(MN)/H9 Clone 4 ered by continuous flow centrifugation through a 25 to were also prepared. These and a typical H9 microvesicle 50% sucrose density gradient. The gradient was monipreparation were analyzed by SDS-PAGE (Fig. 1) . The H9 tored for UV absorbance and collected in 25-ml fractions.
microvesicle preparation contains a large number of minor Each fraction was diluted to less than 20% sucrose and protein bands and a single major band near 42 kDa (actin). centrifuged at 100,000 g for 1 hr. The pellet from each
In addition to the easily seen viral gag proteins (p24 CA , fraction was resuspended in 2 ml of sterile TNE buffer. Note. Clarified culture supernatant from each cell line was centrifuged at 100,000 g for 45 min. The pellets were resuspended in buffer, centrifuged through 20% sucrose at 100,000 g for 1 hr, and resuspended at 5001 relative to the starting material. These preparations were analyzed to determine their total protein, HIV-1 p24 CA , HLA DR, and b2-M concentrations. As an index of relative purity, the ratio of p24 CA concentration to HLA concentration (i.e., the sum of the HLA DR and b2-M concentrations) were calculated. Preparations from the uninfected cell lines all contained proteinaceous, particulate material (i.e., microvesicles) that was dense enough to pass through 20% sucrose during centrifugation. As shown by the p24 CA concentrations, the HIV-1(MN)/H9 Clone 4 line produced substantially more virus than the two prototypical HIV-1 producing cell lines, HIV-1(B)/H9, and HIV-1(MN)/H9, and had a better ratio of p24
Ca to HLA. However, the best ratios were found for the preparations of HIV-1(MN) Clone 4 produced by CEM-SS and MOLT-3 cells.
croscopy and typical cells were seen to have numerous fuged at low speed to prepare a cell pellet for electron microscopy, it is apparent that many of the microvesicles microvesicles of various shape, size, and electron density around their periphery (Fig. 2) . Since the cells were centriwould have remained in the supernatant. Thus, the number seen here greatly underrepresents the number found in the cell culture supernatant. These amorphous particles range in size from 50 to 1000 nm in diameter and many appear to be budding from the cell's surface. The larger ''particles'' may be portions of cells sliced out of plane. Most of the microvesicles have an electron density similar to that of the cell's cytoplasm. However, some were significantly less dense with lightly defined margins and, less frequently, others were nearly electron transparent with clearly defined margins (Fig. 2, inset) . For comparison, sucrose density gradient purified HIV-1(MN)/H9, HIV-1(MN)/H9 Clone 4, and H9 microvesicles were also examined by electron microscopy (Fig. 3) . The HIV-1(MN)/ H9 preparation contained many HIV-1 particles as identified by the electron dense cores of the mature particles. However, there were significantly more particles that appear to be microvesicles than viruses. The HIV-1(MN)/H9 Clone 4 preparation consisted primarily of HIV-1 particles and relatively few microvesicles. The purified H9 microvesicle preparation contained the same complement of heterogeneous particles as seen around the cell in 67% (wt/vol) CsCl cushions, and centrifuged under condilose filter and probed with 32 P-labeled-cDNA probes. Figure 4B shows a Northern blot that was hybridized with tions identical to the first nucleic acid isolation. This was performed to determine whether all of the polynucleoa probe detect glyceraldehyde-3-phosphate dehydrogenase (G3PDH) transcripts. A significant amount of tides were isolated from the disrupted H9 microvesicles. There was no detectable nucleic acid absorbance after G3PDH mRNA was observed. No HIV-1 mRNA was detected (data not shown). the second centrifugation step. From one lot (P3552), 214 { 4 mg of RNA and 41 { 3 mg of DNA was obtained To determine if viral envelope proteins were associated with microvesicles, HIV-1(MN)/H9 was purified from six from a 20 mg protein-containing H9 microvesicle pellet. Another lot (P3548) yielded 200 { 4 mg of RNA and 104 liters of cell culture supernatant by continuous flow ultracentrifugation in a sucrose density gradient. The gradient { 3 mg of DNA. The nucleic acid isolated by this procedure was judged to be of high purity since the OD 260 / was monitored for UV absorbance (A 280 ) and fractions were collected. Fractions were analyzed for sucrose, OD 280 ratio of all samples was §2.0. RNA isolated by the CsCl cushion procedure was fractionated on a denaturp24 CA , HLA DR, and gp120 SU concentrations (Fig. 5A) . The 25 to 50% sucrose density gradient was found in fractions ing formaldehyde/agarose gel. Figure 4A shows the ethidium-stained gel after fractionating 2.5 to 40 mg of 11 through 40, respectively. The earlier fractions contained material that was not dense enough to penetrate 25% RNA. The major bands that are visible are the 28S and 18S ribosomal bands and a faint band at the bottom of sucrose. Most of the sucrose density gradient fractions had similar A 280 values, indicating that they had similar the gel, probably tRNA and other low molecular weight RNA species. The RNA was transferred onto a nitrocellutotal protein concentrations. A discrete p24 CA peak (i.e., the HIV-1 virions) was found between fractions 25 and 30.
crose density gradient and the resulting fractions analyzed by HLA DR RIA and b2-M RIA. As can be seen in Particulate material containing HLA DR was found in all of the gradient fractions, demonstrating the presence of Fig. 6 , the PBL microvesicles banded in a wide range of densities and contained both HLA DR and b2-M. An microvesicles in the entire sucrose density gradient. There appeared to be two peak concentrations of microvesicles electron micrograph was prepared from the material in fraction 12 (data not shown). Numerous microvesicles in the gradient, one found between fractions 19 and 24 and the other between fractions 27 and 32. The distribution of were seen, demonstrating that these particles are produced not only by transformed T-cells such as H9, but gp120 SU closely paralleled that of p24 CA and not the bimodal HLA DR distribution, suggesting that little if any also by human PBL. gp120 SU was found on the microvesicles. Approximately 5.8 times more p24 CA was found in the virus peak (fractions DISCUSSION 25 through 30) than HLA DR. The same cultures, used as a source of material for this experiment, were passaged There are a large number of publications supporting weekly for several weeks. Six liters of cell culture supernathe concept that cellular proteins are physically associtant were processed and analyzed as before (Fig. 5B) . The ated with HIV-1 (Gelderbloom et al., 1987; Kannagi et al., 25 to 50% sucrose density gradient was found in fractions 1987; Schols et al., 1992; Arthur et al., 1992 ; Meerloo et 16 through 39, respectively. As in the previous experiment, al., 1993; Orentas et al., 1993; Franke et al., 1994;  Ott et a discrete HIV-1 peak (i.e., p24 CA ) was observed among al., 1995b Gluschankof et al., 1996) . Since cellular a broad distribution of HLA DR. However, the distribution proteins bound to nonviral particles (i.e., microvesicles) of HLA DR was significantly altered. The amount of HLA can copurify with virus, the finding of cellular proteins in DR in the first peak was greatly increased over that of the purified virus preparations does not indicate that these previous purification. Also, less virus was produced and proteins are necessarily physically associated with the now approximately 2.8 times as much HLA DR than p24 CA virus particles. In this report, we characterize microveswas found in the virus peak (fractions 22 through 30).
icles which copurify with HIV-1 during sucrose density PHA-stimulated human peripheral blood lymphocytes centrifugation. The amount and type of cellular proteins (PBL) were analyzed to determine if activated cells also found in purified virus preparations were shown to be produced microvesicles. Approximately 7.5 1 10 8 PBLs affected by the virus isolate and cell line. In fact, the were recovered from the Ficoll-Hypaque centrifugation amount of HLA DR exceeded the amount of p24 CA in of the PBL from a single lymphapheresis pack. PHApurified preparations of two of the prototypical HIV-1 isoactivated PBL were cultured in roller bottles and harlates, HIV-1(B)/H9 and HIV-1(MN)/H9. Preparation of sinvested twice weekly until a total of 10 liters was obtained.
gle cell clones of HIV-1(MN)/H9 resulted in a biological clone, HIV-1(MN)/H9 Clone 4, which was found to yield The clarified culture supernatant was banded in a su- , and HLA DR were determined for each fraction by RIA. The 25 to 50% sucrose density gradient starts at fraction 11 and ends at fraction 40, respectively. The earlier fractions are material that was not dense enough to penetrate the gradient. HLA DR was detected in all of the fractions and in peak fractions at concentrations approximately one-tenth that of p24 CA . In general, viral envelope protein (gp120 SU ) is found in parallel with p24 CA and not in parallel with the HLA DR, suggesting that little or no gp120 SU is associated with the microvesicles. (B) The same cultures used for the first experiment were passaged twice weekly for several weeks and six liters of cell culture fluid were processed as before. The sucrose density gradient starts at fraction 16 and ends at fraction 39. The amount of p24 CA in peak fractions was approximately one-fourth of that found in the first experiment while the concentrations of HLA DR were approximately 5 times higher than before. Again, most of the gp120 SU is found in parallel with p24 CA and not in parallel with the HLA DR, suggesting that little or no gp120 SU is associated with the microvesicles. However, some gp120 SU may be associated with microvesicles that banded at a higher density than the virus particles. These two experiments demonstrated that over time the ratio of viral protein to HLA DR can be highly variable. Note that the HLA DR concentration scales are different in A and B.
not only much more virus per liter than the two prototypiand cell line affect the relative concentrations of viral to cellular proteins, but there may be variation between cal cell lines, but also much more p24
CA than HLA DR. These findings suggest that not only do the virus isolate individual cells in a mixed population. At present, we have no data indicating whether this is a property of the cell range in a sucrose density gradient. Consequently, the ratio of viral-associated protein to protein contributed by clone, the two proviruses contained in this cell clone (Ott et al., 1995a) , or both. In addition to H9, all of the uninmicrovesicles is also affected by which fractions are selected for inclusion in the ''virus pool.'' Typically, fractions fected T-cell lines analyzed, CEM-SS, DAUDI, and MOLT-3, produced microvesicles that banded at the same denare selected based on the A 280 and sucrose density profiles. As shown in Fig. 5A , selection of fractions 25 sity as HIV-1. Implicitly, microvesicles purified from cell lines such as CEM-SS and MOLT-3 that do not produce through 30 would yield a HIV-1 p24 CA to HLA DR ratio of 5.8:1. However, if fractions 22 through 35 had been HLA DR did not contain any HLA DR but did contain b2-M. The reciprocal was found for the b2-M negative cell pooled, the result would have been a HIV-1 p24 CA to HLA DR ratio of 2.9:1. line DAUDI. Previous reports have indicated that infection of T-cell lines can up-regulate, down-regulate, or have no Our finding that little if any gp120 SU was found associated with microvesicles when fractionated by sucrose effect on the cell surface expression of various cellular proteins Wrightham et al., 1991; Ker- gradient centrifugation may indicate that gp120 SU was not distributed in a random fashion on the surface of kau et al., 1989; Stevenson et al., 1987; Mann et al., 1988; Noraz et al., 1995) . Here we observed that infection of HIV-1-infected cells and that the viruses and microvesicles bud from different topological sites. However, there CEM-SS, DAUDI, and MOLT-3 cells with HIV-1(MN)/H9 Clone 4 virus did not greatly effect the amount of HLA was some evidence that a little gp120 SU may have been associated with microvesicles that banded at a slightly DR found in viral pellets relative to the analogous microvesicle preparations within the time period examined.
higher density than HIV-1 particles (see Fig. 5B ). The finding that CD43 and CD63 appeared to be primarily We have produced and purified a large number of HIV-1(MN)/H9 preparations and found them to have a wide virion-associated and HLA-DQ was associated only with microvesicles (Gluschankof et al., 1997) is consistent range of HIV-1 p24 CA to HLA DR ratios (data not shown). Two reasons for this variability are now evident. First, with the concept of separate budding sites. The finding that HIV-1 buds almost exclusively from the basolateral the amount of HIV-1 and microvesicles produced was shown to vary over time in HIV-1(MN)/H9 cultures. An surface of polarized VERO cells (Owens et al., 1991) provides direct evidence that HIV-1 particles can bud from early harvest yielded approximately 5.8 times as much HIV-1 p24 CA than HLA DR in the virus peak while virus specific topological sites. Perhaps the budding site of microvesicles is from a different location. An alternative harvested from later passaged cells had approximately 2.8 times as much HLA DR than HIV-1 p24 CA . Second, explanation for the lack of gp120 SU on microvesicles is derived from the finding that envelope proteins require the density of microvesicles is more heterogeneous than HIV-1, causing them to be distributed over a broader association with the viral Gag precursor under the plasma membrane in order to be included in virions (Yu 1 (Braaten et al., 1996) . It has also been shown that the presence of viral-associated cellular adhesion molecules et al., 1992) . It is possible that without the Gag association with gp120 SU , either the viral envelope proteins are will enhance viral infectivity of CD4-negative cells (Castilletti et al., 1995) . Cellular cytoskeletal proteins, actin, eznot included in microvesicles or they are unstably incorporated and consequently lost.
rin, moesin, and cofilin (Ott et al., 1996) are located in the virion interior. It is unknown how these cellular proteins PHA activated human PBLs were also shown to produce microvesicles that incorporated cellular proteins associate with the virus particles and if they participate in the virus replication cycle. Numerous other cellular (Fig. 6 ). It has recently been reported that B-lymphocytes secrete antigen presenting vesicles (Raposo et al., 1996) proteins have been identified in purified preparations of HIV-1. It is not known if these are physically associated that are similar to the microvesicles described here. We have previously shown that the HLA DR on HIV-1 is funcwith HIV-1 particles and, if so, whether or not they have a role in the virus replication cycle. Identification of which tional since it can serve in superantigen presentation to human T-cells (Rossio et al., 1995) . Thus, it is possible cellular proteins are associated with the virus is a prerequisite to studying the potential functions of cellular prothat cellular proteins on microvesicles and HIV-1 may have immune functions. Experiments are in progress to teins in the virus replication cycle. The development of various purification strategies to separate microvesicles determine if class II molecules on HIV-1 and microvesicles can properly present antigens or if there is improper from HIV-1 particles and the use of cell lines that produce fewer microvesicles will greatly enhance our ability to presentation resulting in anergy and/or apoptosis.
In addition to proteins, microvesicles were also shown identify virion-associated cellular proteins. to contain both RNA and DNA. Approximately 10 mg of RNA and 4 mg of DNA were found per mg of protein. The ACKNOWLEDGMENTS major RNA species in microvesicles were ribosomal 28S
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It does not appear that many of the predominant surBraaten, D., Franke, E. K., and Luban, J. (1996) . Cyclophilin A is required face antigens (i.e., HLA DR, class I, and b2M) are refor the replication of group M human immunodeficiency virus type quired for infection in vitro because it is possible to pro-1 (HIV-1) and simian immunodeficiency virus SIV CPZ GAB but not group O HIV-1 and other primate immunodeficiency viruses. J. Virol. duce infectious HIV-1 stocks devoid of these proteins by 70, 4220-4227. propagation in cells which do not contain these cellular Chan, W. L., Rodgers, A., Grief, C., Almond, N., Ellis, S., Flanagan, B.,
proteins (Bess, unpublished data) . However, it has been Silvera, P., Bootman, J., Stott, J., Kent, K., and Bomford, R. (1995) . Immu- shown that cyclophilin associates with the p24 CA domain nization with class I human leukocyte antigen can protect macaques of the Gag polypeptide of HIV-1 (Luban et al., 1993) and against challenge infection with SIV MAC-23H . AIDS 9, 223-228. Castilletti, C., Capobianchi, M. R., Abbate, I., Ficociello, B., Amegilo, F., is required during the infection process by group M HIV-
